Stock ACOG ALPHA COGNITION INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Alpha Cognition Inc.

Equities

ACOG

CA02074J2048

Market Closed - Canadian Securities Exchange
Other stock markets
 15:32:15 2024-05-29 EDT 		5-day change 1st Jan Change
0.725 CAD -2.03% Intraday chart for Alpha Cognition Inc. +5.07% +9.85%
05-15 Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-04 Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period
MT
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Alpha Cognition to Present at the Life Science Investor Forum March 7th
AQ
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease
BU
Alpha Cognition Inc. Files Composition-Of-M Matter Patent
CI
Alpha Cognition Provides Business Update
BU
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment
BU
Alpha Cognition Inc. announced that it has received $8.45 million in funding
CI
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering
BU
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease
AQ
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
BU
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease
CI
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering
MT
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering
BU
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering
BU
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering
BU
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT
AQ
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACOG Stock
  4. News Alpha Cognition Inc.